| Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and … SR Irani, S Alexander, P Waters, KA Kleopa, P Pettingill, L Zuliani, ... Brain 133 (9), 2734-2748, 2010 | 1503 | 2010 |
| Morvan syndrome: clinical and serological observations in 29 cases SR Irani, P Pettingill, KA Kleopa, N Schiza, P Waters, C Mazia, L Zuliani, ... Annals of neurology 72 (2), 241-255, 2012 | 558 | 2012 |
| KCNQ2 is a nodal K+ channel JJ Devaux, KA Kleopa, EC Cooper, SS Scherer Journal of Neuroscience 24 (5), 1236-1244, 2004 | 493 | 2004 |
| Bipap improves survival and rate of pulmonary function decline in patients with ALS KA Kleopa, M Sherman, B Neal, GJ Romano, T Heiman-Patterson Journal of the neurological sciences 164 (1), 82-88, 1999 | 468 | 1999 |
| A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis P Zisimopoulou, P Evangelakou, J Tzartos, K Lazaridis, V Zouvelou, ... Journal of autoimmunity 52, 139-145, 2014 | 314 | 2014 |
| Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems BM Altevogt, KA Kleopa, FR Postma, SS Scherer, DL Paul Journal of Neuroscience 22 (15), 6458-6470, 2002 | 292 | 2002 |
| Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes L Bataller, KA Kleopa, GF Wu, JE Rossi, MR Rosenfeld, J Dalmau Journal of Neurology, Neurosurgery & Psychiatry 78 (4), 381-385, 2007 | 284 | 2007 |
| Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C VA Street, CL Bennett, JD Goldy, AJ Shirk, KA Kleopa, BL Tempel, ... Neurology 60 (1), 22-26, 2003 | 256 | 2003 |
| Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations KA Kleopa, LB Elman, B Lang, A Vincent, SS Scherer Brain 129 (6), 1570-1584, 2006 | 167 | 2006 |
| Diverse trafficking abnormalities of connexin32 mutants causing CMTX SW Yum, KA Kleopa, S Shumas, SS Scherer Neurobiology of disease 11 (1), 43-52, 2002 | 147 | 2002 |
| Molecular genetics of X-linked Charcot-Marie-Tooth disease KA Kleopa, SS Scherer Neuromolecular medicine 8, 107-122, 2006 | 145 | 2006 |
| Autoimmune channelopathies and related neurological disorders A Vincent, B Lang, KA Kleopa Neuron 52 (1), 123-138, 2006 | 144 | 2006 |
| Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes KA Kleopa, JL Orthmann, A Enriquez, DL Paul, SS Scherer Glia 47 (4), 346-357, 2004 | 142 | 2004 |
| Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects I Sargiannidou, N Vavlitou, S Aristodemou, A Hadjisavvas, K Kyriacou, ... Journal of Neuroscience 29 (15), 4736-4749, 2009 | 140 | 2009 |
| Cellular mechanisms of connexin32 mutations associated with CNS manifestations KA Kleopa, SW Yum, SS Scherer Journal of neuroscience research 68 (5), 522-534, 2002 | 127 | 2002 |
| How do mutations in GJB1 cause X-linked Charcot–Marie–Tooth disease? KA Kleopa, CK Abrams, SS Scherer Brain research 1487, 198-205, 2012 | 125 | 2012 |
| Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy KA Kleopa, A Drousiotou, E Mavrikiou, A Ormiston, T Kyriakides Human molecular genetics 15 (10), 1623-1628, 2006 | 111 | 2006 |
| Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter K Markoullis, I Sargiannidou, N Schiza, A Hadjisavvas, F Roncaroli, ... Acta neuropathologica 123, 873-886, 2012 | 90 | 2012 |
| X‐linked Charcot‐Marie‐tooth disease SS Scherer, KA Kleopa Journal of the Peripheral Nervous System 17 (s3), 9-13, 2012 | 88 | 2012 |
| MuSK autoantibodies in myasthenia gravis detected by cell based assay—a multinational study AI Tsonis, P Zisimopoulou, K Lazaridis, J Tzartos, E Matsigkou, ... Journal of neuroimmunology 284, 10-17, 2015 | 84 | 2015 |
